MY [CHINA MING YANG WIND POWER] 6-K: (Original Filing)

[MY Reports Second Quarter 2011 Results, Continues to Increase Orders Zhongshan, China, August 15, 2011 – China Ming Yang Wind Power Group Limited (“Ming Yang” or the “Company”) (NYSE: MY), a leading wind turbine manufacturer in China, today announced its unaudited financial results for the second quarter ended June 30, 2011. Second Quarter 2011 Financial Highlights: • Total wind turbine] [MY Announces Share Repurchase Program Zhongshan, China, August 15, 2011 – China Ming Yang Wind Power Limited (“Ming Yang” or the “Company”) (NYSE: MY), a leading wind turbine manufacturer in China, today announced that its Board of Directors has approved a share repurchase program, effective immediately. Under the program, Ming Yang is authorized to repurchase up to US$50 million worth]

By | 2016-03-01T01:57:14+00:00 August 16th, 2011|Categories: Chinese Stocks, MY, SEC Original|Tags: , , , , , |0 Comments

MY [CHINA MING YANG WIND POWER] 6-K: MY Reports Second Quarter 2011 Results, Continues to

[MY Reports Second Quarter 2011 Results, Continues to Increase Orders Zhongshan, China, August 15, 2011 – China Ming Yang Wind Power Group Limited (“Ming Yang” or the “Company”) (NYSE: MY), a leading wind turbine manufacturer in China, today announced its unaudited financial results for the second quarter ended June 30, 2011. Second Quarter 2011 Financial Highlights: • Total wind turbine] [MY Announces Share Repurchase Program Zhongshan, China, August 15, 2011 – China Ming Yang Wind Power Limited (“Ming Yang” or the “Company”) (NYSE: MY), a leading wind turbine manufacturer in China, today announced that its Board of Directors has approved a share repurchase program, effective immediately. Under the program, Ming Yang is authorized to repurchase up to US$50 million worth]

By | 2016-03-01T01:59:20+00:00 August 16th, 2011|Categories: Chinese Stocks, MY, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] NT 10-Q: (Original Filing)

[PART II -- RULES 12b-25(b) AND (c) ½ ½ ½ ½ ½ [ X ] ½ ½ ½ ½ (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or]

By | 2016-03-01T05:11:38+00:00 August 16th, 2011|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] NT 10-Q: PART II — RULES 12b-25(b) AND (c) ½

[PART II -- RULES 12b-25(b) AND (c) ½ ½ ½ ½ ½ [ X ] ½ ½ ½ ½ (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or]

By | 2016-03-01T05:12:24+00:00 August 16th, 2011|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

HTHT [China Lodging,] 6-K: (Original Filing)

[Contact Information Ida Yu Investor Relations Manager Tel: 86 (21) 6195 9561 ir@htinns.com Email: http://ir.htinns.com China Lodging Group, Limited Reports Second Quarter of 2011 Financial Results • 1 , at the high end of the guidance previously announced Net Revenues increased 24.8% year-over-year for the second quarter to RMB547.7 million (US$84.7 million) • Adjusted EBITDA from operating hotels (non-GAAP) was]

By | 2016-03-03T05:05:03+00:00 August 16th, 2011|Categories: Chinese Stocks, HTHT, SEC Original|Tags: , , , , , |0 Comments

HTHT [China Lodging,] 6-K: Contact Information Ida Yu Investor Relations Manager Tel:

[Contact Information Ida Yu Investor Relations Manager Tel: 86 (21) 6195 9561 ir@htinns.com Email: http://ir.htinns.com China Lodging Group, Limited Reports Second Quarter of 2011 Financial Results • 1 , at the high end of the guidance previously announced Net Revenues increased 24.8% year-over-year for the second quarter to RMB547.7 million (US$84.7 million) • Adjusted EBITDA from operating hotels (non-GAAP) was]

By | 2016-03-03T05:08:21+00:00 August 16th, 2011|Categories: Chinese Stocks, HTHT, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] CORRESP: (Original Filing)

[China Pharma Holdings, Inc. Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 August 16, 2011 VIA EDGAR Ms. Tabatha Akins Staff Accountant Division of Corporation Finance 100 F Street, NE Re: China Pharma Holdings, Inc. Form 10-K for the fiscal year ended December 31, 2010 Filed March 3, 2011 and Amended March 17, 2011 Form 10-Q for]

By | 2016-03-03T19:14:40+00:00 August 16th, 2011|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] CORRESP: China Pharma Holdings, Inc. Second Floor, No. 17,

[China Pharma Holdings, Inc. Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 August 16, 2011 VIA EDGAR Ms. Tabatha Akins Staff Accountant Division of Corporation Finance 100 F Street, NE Re: China Pharma Holdings, Inc. Form 10-K for the fiscal year ended December 31, 2010 Filed March 3, 2011 and Amended March 17, 2011 Form 10-Q for]

By | 2016-03-03T19:17:04+00:00 August 16th, 2011|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CNET [ChinaNet Onlines,] 8-K: (Original Filing)

[ChinaNet Onlines Reports Second Quarter 2011 Earnings Q2 gross margin expanded by 1,145 basis points year-over-year to 62.2% Signed 86 new customers to Liansuo.com in Q2 2011 $4.1 million operatingsh flows in first six months of 2011 6 BEIJING, August 1 Summary Financials Second Quarter 2011 Results (USD) Q2 2011]

By | 2016-02-08T12:02:32+00:00 August 16th, 2011|Categories: Chinese Stocks, CNET, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar